Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies

Keyphrases

• Glioma 100%
• Normal Brain 100%
• Positron Emission Tomography Study 100%
• Glucose Utilization 100%
• Barbiturate Coma 100%
• Barbiturates 55%
• FDG Positron Emission Tomography 33%
• Tumor 22%
• Tumor Control 22%
• Gray Matter 22%
• Neuronal Activity 22%
• Basal Ganglia 22%
• Positron Emission Tomography 22%
• Cerebral Glucose Metabolism 22%
• Utilization Rate 22%
• Cerebellar Cortex 22%
• Control Site 22%
• Control Tissue 22%
• Brain Tumor 11%
• Magnetic Resonance Imaging 11%
• White Matter 11%
• Synaptic Activity 11%
• Novel Therapeutics 11%
• Computerized Tomography 11%
• Neoplastic Tissue 11%
• Cerebral Glioma 11%
• Hypermetabolic 11%
• Neuronal Metabolism 11%
• Contralateral Hemisphere 11%
• Deep Tumors 11%
• Tumor Invasion 11%
• 2-Deoxy-d-glucose (2-DG) 11%
• Cerebellar Tumor 11%
• Non-neoplastic 11%
• Mean Reduction 11%
• Malignant Glioma 11%
• Cerebral Tissue 11%
• Glucose Consumption 11%
• Fluorine-18 11%
• Differential Effects 11%

Medicine and Dentistry

• positron emission tomographic scan 100%
• Ganglioglioma 100%
• Barbiturate 100%
• Glucose Utilization 100%
• Coma 100%
• Neoplasm 44%
• Contralateral 22%
• Thalamus 22%
• Basal Ganglia 22%
• Cerebellar Cortex 22%
• Gray Matter 22%
• Intracranial Tumor 11%
• Computer Assisted Tomography 11%
• Magnetic Resonance Imaging 11%
• Hemisphere 11%
• Fluorine-18 11%
• Glioblastoma 11%
• Glucose Intake 11%
• Tumor Invasion 11%
• Wakefulness 11%

Neuroscience

• positron emission tomographic scan 100%
• Barbiturate 100%
• Coma 100%
• Gray Matter 22%
• Neuronal Activity 22%
• Basal Ganglia 22%
• Thalamus 22%
• Cerebellar Cortex 22%
• Metabolic Pathway 11%
• Magnetic Resonance Imaging 11%
• Intracranial Tumor 11%
• Computed Tomography 11%
• Fluorine-18 11%
• Wakefulness 11%
• 2-Deoxy-D-Glucose 11%